Fig. 1
A feasible workflow of artificial intelligence driven-tumor drug resistance model in basic studies and clinical practice
Fig. 1 | Molecular Cancer
A feasible workflow of artificial intelligence driven-tumor drug resistance model in basic studies and clinical practice
Molecular Cancer